The Role of HPV Screening in Cervical Cancer Prevention
In collaboration with Roche, Premier Integrated Labs (PIL) hosted a successful symposium at The Vertical, Bangsar South, with over 50 attendees including GPs, hospitals, government agencies, and non-profit organizations on 8th December 2024. The event aimed to raise awareness of the critical issue of cervical cancer elimination and the importance of HPV primary screening in early detection and prevention. The symposium featured esteemed speakers such as Dr. Chew Ghee Kheng, Dr. Yogeeta A/P Gunasagran, and Dr. Khoo Su Pei, who shared their expertise on HPV screening and its significance in reducing cervical cancer mortality rates.
PIL is proud to support this effort, having processed over 60,000 HPV screening samples as part of government initiatives this year. We extend our gratitude to all participants for their dedication to improving patient care and contributing to the national effort to eliminate cervical cancer, building a future where women’s health is prioritized, and cervical cancer is no longer a threat.
